Literature DB >> 24018774

Roles of accessory proteins for heterotrimeric G-protein in the development of cardiovascular diseases.

Motohiko Sato1.   

Abstract

Signal processing via heterotrimeric G-proteins is one of the most widely used systems for signal transfer across the cell membrane. This signaling system regulates most physiological and pathophysiological processes in mammals and is therefore the primary target of many pharmaceutical agents. The heterotrimeric G-protein signaling system includes the G-protein-coupled receptor (GPCR), heterotrimeric G-proteins, and effectors. The G-proteins are activated by the GPCR to mediate a signal to effector molecules. However, other players in this system that regulate the activation status of heterotrimeric G-proteins independently of GPCR have been identified. Such accessory proteins for heterotrimeric G-protein can provide additional signal input to the G-protein signaling system, or may act as alternative binding partners of G-protein subunits serving as yet unknown roles in cells. It has been reported that this class of proteins is expressed in the cardiovascular system and contributes to signal integration involved in the various diseases. This review provides an overview of the current understanding of accessory proteins for heterotrimeric G-proteins in their 4 functional subsets, including guanine nucleotide exchange factors (GEFs), guanine nucleotide dissociation inhibitors (GDIs), GTPase-activating proteins (GAPs), and Gβγ-interacting proteins, and discusses their roles in the development of cardiovascular diseases. Better understanding of these components may contribute new insight into the complex network of molecules governing GPCR signaling in the cardiovascular system.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24018774     DOI: 10.1253/circj.cj-13-0705

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Phosphorylation of the Gα protein Gpa2 promotes protein kinase A signaling in yeast.

Authors:  Shan Huang; Alex Benben; Robert Green; Nina Cheranda; Grace Lee; Benita Joseph; Shannon Keaveney; Yuqi Wang
Journal:  J Biol Chem       Date:  2019-11-05       Impact factor: 5.157

Review 2.  β-Adrenergic receptor, an essential target in cardiovascular diseases.

Authors:  Daniel Chikere Ali; Muhammad Naveed; Andrew Gordon; Fatima Majeed; Muhammad Saeed; Michael I Ogbuke; Muhammad Atif; Hafiz Muhammad Zubair; Li Changxing
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

3.  Protection of cardiomyocytes from the hypoxia-mediated injury by a peptide targeting the activator of G-protein signaling 8.

Authors:  Motohiko Sato; Masahiro Hiraoka; Hiroko Suzuki; Miho Sakima; Abdullah Al Mamun; Yukiko Yamane; Takayuki Fujita; Utako Yokoyama; Satoshi Okumura; Yoshihiro Ishikawa
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

4.  Activator of G-protein signaling 8 is involved in VEGF-induced choroidal neovascularization.

Authors:  Hisaki Hayashi; Abdullah Al Mamun; Masayuki Takeyama; Aya Yamamura; Masahiro Zako; Rina Yagasaki; Tsutomu Nakahara; Motohiro Kamei; Motohiko Sato
Journal:  Sci Rep       Date:  2019-02-07       Impact factor: 4.379

5.  Prediction of G Protein-Coupled Receptors with SVM-Prot Features and Random Forest.

Authors:  Zhijun Liao; Ying Ju; Quan Zou
Journal:  Scientifica (Cairo)       Date:  2016-07-27

Review 6.  Engineering G protein-coupled receptor signalling in yeast for biotechnological and medical purposes.

Authors:  Bettina Lengger; Michael K Jensen
Journal:  FEMS Yeast Res       Date:  2020-02-01       Impact factor: 2.796

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.